Analyst consensus rating

Cabaletta Bio Analyst Rating: Strong Buy

Direct answer

Cabaletta Bio's consensus rating is Strong Buy.

8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $11.75.
Forecast evidence checked November 17, 2026.

Get free Cabaletta Bio email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$1.11
Average price target
$11.75
High price target
$20.00
Low price target
$3.00
Low target gap
+170.3%
Target upside
+958.6%
High target gap
+1,701.8%
Target range width
1,531.5%
Consensus rating
Strong Buy
Analysts
8
Evidence date
November 17, 2026
Valid through
November 24, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Cabaletta Bio?

Cabaletta Bio has a verified Strong Buy consensus. The same dataset has an average price target of $11.75.

How far are Cabaletta Bio's low and high targets from the recorded price?

The low target implies +170.3%, while the high target implies +1,701.8%.

How many analysts are included in Cabaletta Bio's consensus?

The verified consensus includes 8 analysts.

How is Cabaletta Bio's target upside or downside calculated?

The average target of $11.75 is divided by the recorded price of $1.11, then one is subtracted to produce +958.6%. This does not guarantee a future return.

When was Cabaletta Bio's analyst forecast verified?

The data was verified on 2026-11-17. The dataset is valid through 2026-11-24.